A Rare Entity of Breast Cancer: Primary Neuroendocrin Carcinoma

Temel Bulgular & Veri:Kliniğimize memede kitle şikayeti ile başvuran invaziv meme kanseri düşünülerek opere edilen ve patolojik inceleme sonucunda memenin nöroenkorin karsinomu saptanan 75 yaşındaki bir hastayı sunuyoruz.

💡

Sonuç & Katkı:Hastamız literatürde memede nöroendokrin tümörü olan en yaşlı hastadır.

🔬Tür:Literatür & Derleme Çalışması

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

Meme kanseri dünyada en sık rastlanan 2. kanserdir ancak memenin nöroendokrin tümörleri oldukça nadirdir. Kliniğimize memede kitle şikayeti ile başvuran invaziv meme kanseri düşünülerek opere edilen ve patolojik inceleme sonucunda memenin nöroenkorin karsinomu saptanan 75 yaşındaki bir hastayı sunuyoruz. Hastamız literatürde memede nöroendokrin tümörü olan en yaşlı hastadır.

Abstract

Breast cancer is the second leading cause of cancer throughout the world, however neuroendocrine tumors of the breast are rarely encountered. Herein we present a 75-year-old patient who was admitted to our clinic due to a mass in her breast and was operated on with a preliminary diagnosis of invasive breast carcinoma, However she was diagnosed with a neuroendocrine tumor after pathologic evaluation. The patient is the oldest one among others with a neuroendocrine tumor in the breast reported in the literature.

🔖

Bu Makaleye Atıf Yap

BOZKURT, M. A., KOCATAŞ, A., ÖZKAN, Y., KALAYCI, M. U., ALIŞ, H. (2014). A Rare Entity of Breast Cancer: Primary Neuroendocrin Carcinoma. Meme Sağlığı Dergisi, Cilt: 10 - Sayı: 4, 242–244. https://ajindex.com/articles/278022

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

Prommegger R, Ensinger C, Steiner P, Sauper T, Profanter C, Margreiter R. Neuroendocrine tumors and second primary malignancy, a relationship with clinical impact? Anticancer Res 2004; 24:1049-1051. (PMID: 15154621) Polat AK, Soran A. Metastatik meme kanseri tanısı alanlarda primer tümör cerrahisinin yeri. Ulusal Cerrahi Dergisi 2010; 26:185-191.
Pagotti M, Marci L, Finzi G, Capella C, Eusebi V, Bussolati G. Neuroendocrine differentiation in carcinoma of the breast: A study of 51 cases. Semin Diagn Pathol 1989; 6:174-188. (PMID: 2503862) Günhan BI, Zekioglu O, Ustün EE, Memis A, Erhan Y. Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histophatological findings. Eur Radiol 2003; 13:788-793. (PMID: 12664118) Adegbola T, Connolly CE, Mortimer G. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature. J Clin Pathol 2005; 58:775-778. (PMID: 15976350) [CrossRef] Nawawi O, Goh KY, Rahmat K. A Rare Case of Primary Infiltrating Neuroendocrine Carcinoma of the Breast Iran J Radiol 2012 November; 9: 212-216. (PMID: 23408015) Samli B, Celik S, Evrensel T, Orhan B, Tasdelen I. Primary neuroendocrine small cell carcinoma of the breast. Arch Pathol Lab Med 2000; 124:296-298. (PMID: 10656743) Böcker W. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics. Verh Dtsch Ges Pathol 2002; 86:116-119. (PMID: 12647359) López-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernadó L, Menendez JA. Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and immunohistochemical profiling. Oncol Rep 2008; 20:1369-1374. (PMID: 19020716) Alonso-Ruano M, López-Bonet E, Huerta-Anaya MV, Vila-Camps E, Bernadó L, Tuca-Rodríguez F, Suarez-Pumariega P, Menendez JA. Synchronous solid neuroendocrine breast carcinoma and abdominal lymphoma: a case report and review of the literature oncol lett. 2013; 5:459-462. (PMID:23419985) Çakabay B, Aksel B, Ünal AE, Bayar S, Kocaoğlu H, Demirci S ve ark. Primer meme kanserinin lokal kontrolünde radyofrekans ablasyon bir seçenek olabilir mi? Ulusal Cerrahi Dergisi 2011; 27:55-59.
Watrowski R, Jäger C, Mattern D, Horst C. Neuroendocrine carcinoma of the breast--diagnostic and clinical implications. Anticancer Res 2012; 32:5079-5082. (PMID:23155283)